Correct me if I am wrong, but I think we also don't have to fund the commercial plants, which will cost about A$500m in total.. ECT has strategically avoided the capital intensity commitments whilst retaining a 49% stake in the IP.
Typically with situations like this, the IP owner usually sells a substantial majority stake in the IP in exchange for its commercialisation. Because there's no alternative, it's a buyer's market for the IP. ECT alluded to this in their revenue model announcement.
Remember, the SPV will house the IP. ECT doesn't need to fund the development of the plants, which will be funded by the third parties, including but not limited to NLC and NMDC. The SPV's revenue will largely translate into bottom line profit with minimal expenses, which at this stage is predicted to be ~$5/tonne. Once the deal is over the line, investors can then begin using a risk adjusted NPV model to value the asset, which should see a re-rate of the market value.
- Forums
- ASX - By Stock
- ECT
- Ann: India Project Update
Ann: India Project Update, page-178
-
-
- There are more pages in this discussion • 22 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ECT (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.515M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $7 | 2.454K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
50 | 18738002 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 12408157 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
49 | 18638002 | 0.003 |
19 | 13255353 | 0.002 |
10 | 17300024 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 11264617 | 21 |
0.005 | 4374813 | 26 |
0.006 | 5239567 | 10 |
0.007 | 1118334 | 6 |
0.008 | 332213 | 4 |
Last trade - 15.44pm 12/07/2024 (20 minute delay) ? |
Featured News
FWD
Queensland's housing crisis an opportunity for ASX builder Fleetwood – and taxpayer cash a safe harbour from the storm
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
ECT (ASX) Chart |